These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7824875)

  • 1. Ursodeoxycholic acid treatment of cholesterol gallstone disease.
    Paumgartner G; Pauletzki J; Sackmann M
    Scand J Gastroenterol Suppl; 1994; 204():27-31. PubMed ID: 7824875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy.
    Sackmann M; Koelbl R; Pauletzki J; Cremer P; Klueppelberg UG; von Ritter C; Sauter G; Holl J; Seidel D; Paumgartner G
    Z Gastroenterol; 1995 Oct; 33(10):585-9. PubMed ID: 7502550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary lithotripsy by extracorporeally generated shock waves.
    Sackmann M; Paumgartner G
    Recenti Prog Med; 1992; 83(7-8):400-6. PubMed ID: 1529154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary stones: treatment by shock-wave lithotripsy.
    Sackmann M; Sauerbruch T; Delius M; Holl J; Brendel W; Paumgartner G
    Surg Endosc; 1988; 2(4):224-6. PubMed ID: 3242145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of gallstone lithotripsy.
    Adwers JR
    Hosp Pract (Off Ed); 1989 Jul; 24(7):83-90. PubMed ID: 2501329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal shockwave lithotripsy of gallstones. Retrospective view and perspectives].
    Adamek HE; Riemann JF
    Z Gesamte Inn Med; 1992 Jul; 47(7):285-90. PubMed ID: 1496836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones.
    Tint GS; Dyrszka H; Sanghavi B; Patel G; Patel S; Shefer S; Salen G
    Gastroenterology; 1992 Jun; 102(6):2042-9. PubMed ID: 1587422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early gallstone recurrence rate after successful shock-wave therapy.
    Sackmann M; Ippisch E; Sauerbruch T; Holl J; Brendel W; Paumgartner G
    Gastroenterology; 1990 Feb; 98(2):392-6. PubMed ID: 2295394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.
    Ponchon T; Barkun AN; Pujol B; Mestas JL; Lambert R
    Gastroenterology; 1989 Aug; 97(2):457-63. PubMed ID: 2744359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extracorporeal shock wave lithotripsy therapy of patients with gallstone].
    Oto M
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):324-9. PubMed ID: 1607792
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors affecting gallstone recurrence after successful extracorporeal shock wave lithotripsy.
    Ochi H; Tazuma S; Kajihara T; Hyogo H; Sunami Y; Yasumiba S; Nakai K; Tsuboi K; Asamoto Y; Sakomoto M; Kajiyama G
    J Clin Gastroenterol; 2000 Oct; 31(3):230-2. PubMed ID: 11034003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.
    Petroni ML; Jazrawi RP; Pazzi P; Zuin M; Lanzini A; Fracchia M; Facchinetti D; Alvisi V; Ferraris R; Bland JM; Heaton KW; Podda M; Northfield TC
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):695-700. PubMed ID: 10912491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piezoelectric extracorporeal shock wave lithotripsy in 93 patients with gallstones.
    Farese A; Pozzi M; Patussi V; Ballerini G; Arena U; Surrenti C
    Ital J Gastroenterol; 1993 Jun; 25(5):251-5. PubMed ID: 8353298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone recurrence after shock-wave therapy.
    Sackmann M; Niller H; Klueppelberg U; von Ritter C; Pauletzki J; Holl J; Berr F; Neubrand M; Sauerbruch T; Paumgartner G
    Gastroenterology; 1994 Jan; 106(1):225-30. PubMed ID: 8276185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extracorporeal shock wave lithotripsy and ursodeoxycholic acid on gallbladder motility.
    Rothstein RD; Brugge WR; Malet PF
    Dig Dis Sci; 1993 Sep; 38(9):1712-7. PubMed ID: 8359085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal shock wave lithotripsy. Experience in treating 245 patients with gallbladder stones.
    Wang BS; Xu GR; He LQ; Zhang YW; Zheng LW; Chen JX; Lin SC; Meng CW
    Chin Med J (Engl); 1990 Jun; 103(6):443-6. PubMed ID: 2119955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallstone lithotripsy.
    Nahrwold DL
    Am J Surg; 1993 Apr; 165(4):431-4. PubMed ID: 8480876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical dissolution of gallstones by oral bile acid therapy.
    Hofmann AF
    Am J Surg; 1989 Sep; 158(3):198-204. PubMed ID: 2672842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.